A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
暂无分享,去创建一个
[1] M. Huestis,et al. One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. , 2015, Journal of Analytical Toxicology.
[2] J. Price. A Trend Analysis of Laboratory Positive Propoxyphene Workplace Urine Drug Screens Before and After the Product Recall , 2015, Journal of addiction medicine.
[3] Octavia M Peck Palmer,et al. Ranitidine interference with standard amphetamine immunoassay. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[4] Robert L Fitzgerald,et al. False-positive interferences of common urine drug screen immunoassays: a review. , 2014, Journal of analytical toxicology.
[5] M. J. Rumpler. Quantitative analysis of 11-nor-9-carboxy-tetrahydrocannbinol (THC-COOH) in urine by LC-MS/MS following a simple filtration. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] B. Greijdanus,et al. Fast and Highly Selective LC-MS/MS Screening for THC and 16 Other Abused Drugs and Metabolites in Human Hair to Monitor Patients for Drug Abuse , 2014, Therapeutic drug monitoring.
[7] B. Greijdanus,et al. Application of Sweat Patch Screening for 16 Drugs and Metabolites Using a Fast and Highly Selective LC-MS/MS Method , 2013, Therapeutic drug monitoring.
[8] A. Wasan,et al. Optimizing urine drug testing for monitoring medication compliance in pain management. , 2013, Pain medicine.
[9] A. Rengarajan,et al. How often do false-positive phencyclidine urine screens occur with use of common medications? , 2013, Clinical toxicology.
[10] R. Heltsley,et al. Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market. , 2013, Journal of analytical toxicology.
[11] J. A. Bourland,et al. Cross-reactivity of tapentadol specimens with DRI methadone enzyme immunoassay. , 2012, Journal of analytical toxicology.
[12] Y. Kaplan,et al. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate. , 2012, Therapeutic drug monitoring.
[13] G. McMillin,et al. Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma. , 2012, Journal of analytical toxicology.
[14] A. Pesce,et al. Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[15] D. Murry,et al. Drug Testing in the Workplace , 2012, Pharmacotherapy.
[16] A. Burton,et al. Urine drug testing: current recommendations and best practices. , 2012, Pain physician.
[17] A. Wu,et al. False-positive urine phencyclidine immunoassay screen result caused by interference by tramadol and its metabolites. , 2012, Annals of emergency medicine.
[18] Robert A Middleberg,et al. Quantitation of amphetamine-type stimulants by LC-MS/MS. , 2012, Methods in molecular biology.
[19] S. Baker,et al. A review of the methods, interpretation, and limitations of the urine drug screen. , 2011, Orthopedics.
[20] J. Baron,et al. The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results. , 2011, Journal of analytical toxicology.
[21] H. Walls,et al. Crossreactivity of Bupropion Metabolite With Enzyme-Linked Immunosorbent Assays Designed to Detect Amphetamine in Urine , 2011, Therapeutic drug monitoring.
[22] L. Manchikanti,et al. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing. , 2011, Pain physician.
[23] J. Magluilo,et al. Dimethylamylamine: a drug causing positive immunoassay results for amphetamines. , 2011, Journal of analytical toxicology.
[24] L. Manchikanti,et al. Urine drug testing in chronic pain. , 2011, Pain physician.
[25] A. Muzyk,et al. Interferences With Urine Drug Screens , 2011, Journal of pharmacy practice.
[26] M. Scott,et al. Frequency of False Positive Amphetamine Screens due to Bupropion Using the Syva Emit II Immunoassay , 2011, Journal of Medical Toxicology.
[27] Q. Shafiq,et al. Urine opiate screening: false-positive result with levofloxacin , 2010, Canadian Medical Association Journal.
[28] Peter L Tenore,et al. Advanced Urine Toxicology Testing , 2010, Journal of addictive diseases.
[29] K. Farmer,et al. Commonly prescribed medications and potential false-positive urine drug screens. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[30] G. McMillin,et al. LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium. , 2010, Methods in molecular biology.
[31] Vincent P Villena. Beating the system: a study of a creatinine assay and its efficacy in authenticating human urine specimens. , 2010, Journal of analytical toxicology.
[32] R. Heltsley,et al. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites. , 2010, Journal of analytical toxicology.
[33] A. Pesce,et al. Unstable propoxyphene metabolite excreted in human urine is detected by liquid chromatography-tandem mass spectrometry. , 2009, Journal of analytical toxicology.
[34] E. Cone,et al. Urine Toxicology Testing in Chronic Pain Management , 2009, Postgraduate medicine.
[35] A. Jenkins,et al. Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone. , 2009, Clinical chemistry.
[36] Agostinho Santos,et al. GC determination of acetone, acetaldehyde, ethanol, and methanol in biological matrices and cell culture. , 2009, Journal of chromatographic science.
[37] Kelly C. Lee,et al. Urine drug screening: practical guide for clinicians. , 2008, Mayo Clinic proceedings.
[38] A. Dasgupta. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. , 2007, American journal of clinical pathology.
[39] R. Weiss,et al. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. , 2007, Journal of substance abuse treatment.
[40] T. Skripuletz,et al. Bupropion Interference With Immunoassays for Amphetamines and LSD , 2007, Therapeutic drug monitoring.
[41] G. McMillin,et al. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS. , 2007, Journal of analytical toxicology.
[42] A. Zebelman,et al. Clinical inquiries. What common substances can cause false positives on urine screens for drugs of abuse? , 2006, The Journal of family practice.
[43] Amadeo J Pesce,et al. Urine drug screening in the medical setting. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[44] J. Valentine,et al. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens. , 1996, Journal of analytical toxicology.
[45] S. Mulé,et al. Confirmation and quantitation of barbiturates in human urine by gas chromatography/mass spectrometry. , 1989, Journal of analytical toxicology.
[46] R. W. Taylor,et al. Simultaneous identification of cocaine and benzoylecgonine using solid phase extraction and gas chromatography/mass spectrometry. , 1987, Journal of analytical toxicology.